|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.54 USD | -0.15% |
|
+5.77% | +24.41% |
| Capitalization | 3.26B 2.76B 2.53B 2.41B 4.45B 303B 4.54B 29.72B 11.69B 146B 12.22B 11.97B 517B | P/E ratio 2026 * |
-7.74x | P/E ratio 2027 * | -7.91x |
|---|---|---|---|---|---|
| Enterprise value | 2.6B 2.21B 2.02B 1.92B 3.55B 242B 3.62B 23.71B 9.33B 117B 9.75B 9.55B 412B | EV / Sales 2026 * |
64x | EV / Sales 2027 * | 23.8x |
| Free-Float |
90.34% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | -0.15% | ||
| 1 week | +5.77% | ||
| Current month | +6.98% | ||
| 1 month | +1.83% | ||
| 3 months | +17.17% | ||
| 6 months | +19.07% | ||
| Current year | +24.41% |
| 1 week | 20.09 |  | 21.8 |
| 1 month | 17.86 | | 23.46 |
| Current year | 15.34 | | 23.77 |
| 1 year | 12.58 | | 23.77 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 79.7 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 2022-04-30 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 2015-07-31 |
Joe Lewcock
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 2015-02-28 |
| Chairman | 66 | 2015-02-28 | |
Jay Flatley
BRD | Director/Board Member | 73 | 2015-03-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | +5.77% | +61.22% | -17.14% | 3.26B | |
| -1.42% | +4.52% | +34.99% | +104.04% | 51.85B | |
| +0.37% | -5.63% | +88.76% | +27.68% | 44.26B | |
| -1.15% | -5.50% | +96.59% | +706.89% | 30.83B | |
| +2.21% | +8.78% | +6.51% | -13.02% | 26.6B | |
| -0.12% | +25.41% | +2.07% | +1,479.87% | 19.48B | |
| -1.07% | -5.43% | +63.34% | -30.09% | 18.8B | |
| -1.36% | +5.08% | +63.91% | +240.94% | 17.28B | |
| -1.61% | -1.14% | +37.44% | -36.15% | 17.18B | |
| -1.26% | +2.97% | +66.53% | - | 15.07B | |
| Average | -0.56% | +4.28% | +52.14% | +273.67% | 24.46B | |
| Weighted average by Cap. | -0.52% | +2.86% | +53.45% | +260.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 40.63M 34.48M 31.6M 30.01M 55.47M 3.78B 56.65M 371M 146M 1.82B 152M 149M 6.44B | 112M 94.84M 86.93M 82.55M 153M 10.39B 156M 1.02B 401M 5.01B 419M 411M 17.72B |
| Net income | -484M -410M -376M -357M -660M -44.97B -674M -4.41B -1.74B -21.7B -1.81B -1.78B -76.68B | -487M -414M -379M -360M -665M -45.32B -679M -4.45B -1.75B -21.87B -1.83B -1.79B -77.28B |
| Net Debt | -659M -559M -512M -487M -899M -61.26B -918M -6.01B -2.36B -29.56B -2.47B -2.42B -104B | -602M -511M -469M -445M -822M -56.02B -840M -5.5B -2.16B -27.03B -2.26B -2.21B -95.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-20 | 20.54 $ | -0.15% | 738,986 |
| 26-04-17 | 20.57 $ | -0.68% | 1,462,091 |
| 26-04-16 | 20.71 $ | -4.47% | 1,515,701 |
| 26-04-15 | 21.68 $ | +7.54% | 1,877,465 |
| 26-04-14 | 20.16 $ | +3.81% | 807,162 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
